EX9:FRA
Exelixis Inc
€51.35
arrow_upward
+0.20%(+0.100) 1D
Oct 1, 8:03:02 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EX9...
Open
€51.35
High
€51.35
Low
€51.35
Mkt. cap
14.47B
Avg. vol.
76.00
Volume
0.00
52-wk high
€52.26
52-wk low
€29.41
No. of employees
1K
Open
€51.35
High
€51.35
Low
€51.35
Mkt. cap
14.47B
Avg. vol.
76.00
Volume
0.00
52-wk high
€52.26
52-wk low
€29.41
No. of employees
1K
News stories
From web sources and news partners
FXEmpire
·
9 hours ago
Exelixis Shares Rising on CABOMETYX Revenue
Profile
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. Wikipedia
About Exelixis Inc
CEOMichael M. Morrissey
Employees1.08K
FoundedNov 15, 1994
HeadquartersAlameda, California, United States
SectorBiotechnology
Websiteexelixis.com